drugset / Trial / NCT01676584
A Study of Single Dose RO6811135 in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
This randomized, double-blind, placebo-controlled study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of RO6811135 in healthy volunteers. Subjects will be randomized in cohorts to receive either single ascending doses of RO6811135 or placebo subcutaneously.
Timeline
- Start
- 2012-09
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO6811135 | Unknown | — | Subcutaneous |
Indications
No indication recorded.